Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
45,438,610
-
Share change
-
+1,386,925
-
Total reported value
-
$1,214,308,493
-
Put/Call ratio
-
7.4%
-
Price per share
-
$26.70
-
Number of holders
-
103
-
Value change
-
+$39,761,438
-
Number of buys
-
64
-
Number of sells
-
48
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2015
As of 31 Dec 2015,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,438,610 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, TANG CAPITAL MANAGEMENT LLC, Invesco Ltd., JANUS CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, Partner Fund Management, L.P., Broadfin Capital, LLC, Cormorant Asset Management, LLC, and STATE STREET CORP.
This page lists
103
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.